Telesta Therapeutics Inc. is a human therapeutics company. The Company is a biotechnology company, which is focused on the licensing/acquisition and development of transformational therapeutics for the treatment of human diseases, such as cancer, immune diseases and targeted rare diseases. The Company focuses on developing drug candidate, Mycobacterium phlei cell wall-nucleic acid complex (MCNA) for the treatment of non-muscle invasive bladder cancer. The Company owns a manufacturing facility for MCNA at Montreal, Quebec. The Company has not generated any revenues.
Industry, Sector and Symbol
Stock Exchange TSE
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolTSE:BNC
CUSIPN/A
WebN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares150,000
Market CapC$3.40 million
Purpose Canadian Financial Incom Etf (TSE:BNC) Frequently Asked Questions
What is Purpose Canadian Financial Incom Etf's stock symbol?
Purpose Canadian Financial Incom Etf trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BNC."
How often does Purpose Canadian Financial Incom Etf pay dividends? What is the dividend yield for Purpose Canadian Financial Incom Etf?
Purpose Canadian Financial Incom Etf announced a monthly dividend on Tuesday, June 26th. Shareholders of record on Monday, July 9th will be given a dividend of 0.085 per share on Monday, July 9th. This represents a $1.02 annualized dividend and a yield of 4.50%. The ex-dividend date of this dividend is Tuesday, June 26th. View Purpose Canadian Financial Incom Etf's Dividend History.
Has Purpose Canadian Financial Incom Etf been receiving favorable news coverage?
Media coverage about BNC stock has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Purpose Canadian Financial Incom Etf earned a news and rumor sentiment score of 0.12 on Accern's scale. They also assigned press coverage about the biotechnology company an impact score of 47.53 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days. View Recent Headlines for Purpose Canadian Financial Incom Etf.
How do I buy shares of Purpose Canadian Financial Incom Etf?
Shares of BNC and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Purpose Canadian Financial Incom Etf's stock price today?
One share of BNC stock can currently be purchased for approximately C$22.67.
How big of a company is Purpose Canadian Financial Incom Etf?
Purpose Canadian Financial Incom Etf has a market capitalization of C$3.40 million.
MarketBeat Community Rating for Purpose Canadian Financial Incom Etf (TSE BNC)
MarketBeat's community ratings are surveys of what our community members think about Purpose Canadian Financial Incom Etf and other stocks. Vote "Outperform" if you believe BNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BNC will underperform the S&P 500 over the long term. You may vote once every thirty days.
